Many BPC-157 products on the market require subcutaneous injection
GIP receptor activation is studied for its effects on adipose tissue metabolism and insulin secretion enhancement, while GLP-1 receptor activation is examined for its appetite suppression, gastric emptying delay, and pancreatic beta-cell protection
Will continue usage for as long as needed
The tissue distribution results showed that the radioactivity intensity in most tissues peaked 1 h after administration, which was slightly later than the peak time of the total radioactivity concentration in plasma (0.167 h)
If your semaglutide has been left unrefrigerated for more than 28 days or exposed to heat, contact PlexusDx for guidance before injecting
Reported reactions are uncommon and usually mild/transient, including: Mild injection-site irritation, redness, or itching Transient headache or light-headedness Temporary changes in energy levels or appetite Rare mild gastrointestinal discomfort If any severe or persistent symptoms occur (e.g., rapid heartbeat, severe headache, or signs of allergic reaction), discontinue use and contact your healthcare provider immediately